Special items: Ovarian Cancer and Us blog best viewed in Firefox

Saturday, January 22, 2011

abstract: Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: A phase I study GOG

Research Highlights

►Radiotherapy is a chemosensitizer to docetaxel in the treatment of ovarian cancer. ►Chemoradiation resulted in stable disease in women with recurrent ovarian cancer. ►Radiotherapy with docetaxel is tolerable in women with recurrent ovarian cancer.

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.